Drugs / Hypertonic lactate
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00529711 | Jul 2005 → Jul 2006 | cardiogenic shock | Innogene Kalbiotech Pte. Ltd | Completed | No outcome recorded |
| Phase 3 | NCT00529490 | Mar 2002 → Jun 2003 | — | Innogene Kalbiotech Pte. Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hypertonic lactate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00529490 ↗ |
| Route | Other | “Parenteral solution administered to a maximal volume of 10 ml/kg BW over the first 12 hours post-CABG” NCT00529490 ↗ |